Skip to main content
. 2023 Feb 15;29(3):605–622. doi: 10.3350/cmh.2022.0342

Figure 3.

Figure 3.

Strategies for management of hepatitis B virus–related hepatocellular carcinoma. AFP, α-fetoprotein; AFP-L3, lectin-bound AFP; DCP, des-gamma carboxy-prothrombin; ELF, enhanced liver fibrosis score; HBcrAg, hepatitis B core-related antigen; HBsAg, hepatitis B surface antigen; HCC, hepatocellular carcinoma; M2BPGi, Mac2 binding protein glycosylation isomer; FIB-4, fibrosis-4.